5 April 2023 in Journal of Medicinal Chemistry
2 January 2025 in Chemical Science
Investigation of the two most widely recognized catalytic pathways for snake venom-secreted phospholipases A2 (svPLA2s): the ‘single-water mechanism’ and the ‘assisted-water mechanism’, in a membrane model.
24 April 2023 in Journal of Chemical Information and Modeling
Snake venom metalloproteinases (SVMPs) are important drug targets against snakebite envenoming, the neglected tropical disease with the highest mortality worldwide. Here, we focus on Russell's viper (Daboia russelii), one of the "big four" snakes of the Indian subcontinent that, together, are responsible for ca. 50,000 fatalities annually. The "Russell's viper venom factor X activator" (RVV-X), a highly toxic metalloproteinase, activates the blood coagulation factor X (FX), leading to the prey's abnormal blood clotting and death. Given its tremendous public health impact, the WHO recognized an urgent need to develop efficient, heat-stable, and affordable-for-all small-molecule inhibitors, for which a deep understanding of the mechanisms of action of snake's principal toxins is fundamental. In this study, we determine the catalytic mechanism of RVV-X by using a density functional theory/molecular mechanics (DFT:MM) methodology to calculate its free energy profile. The results showed that the catalytic process takes place via two steps. The first step involves a nucleophilic attack by an in situ generated hydroxide ion on the substrate carbonyl, yielding an activation barrier of 17.7 kcal center dot mol-1, while the second step corresponds to protonation of the peptide nitrogen and peptide bond cleavage with an energy barrier of 23.1 kcal center dot mol-1. Our study shows a unique role played by Zn2+ in catalysis by lowering the pKa of the Zn2+-bound water molecule, enough to permit the swift formation of the hydroxide nucleophile through barrierless deprotonation by the formally much less basic Glu140. Without the Zn2+ cofactor, this step would be rate-limiting.
27 January 2026 in Journal of Chemical Information and Modeling
Hyaluronidases are widely distributed in nature being ubiquitous in snake species (svHyal). They catalyze the hydrolysis of β-1,4-glycosidic bonds in hyaluronic acid, a critical constituent of the extracellular matrix. This facilitates the spread of venom toxins into the bloodstream, exacerbating tissue damage and systemic toxicity─a rationale for their common designation as "spreading factors". While svHyals are not directly toxic, they substantially contribute to the morbidity and mortality associated with snakebite envenomation, the world's most lethal neglected tropical disease. Despite their important role in tissue penetration, the atomic-level reaction mechanism of these enzymes remains poorly understood. To bridge this knowledge gap, we studied the chemical mechanism of the Hyal-1 enzyme isolated from the Puff Adder viper (Bitis arietans), likely the major contributor to snakebite mortality in sub-Saharan Africa. We evaluated two alternative mechanistic scenarios, based on different protonation states for the active site "assisting residue" (Asp110), and conducted umbrella sampling QM/MM MD simulations (PBE/DZVP-GTH-PBE: AMBER). Our findings indicate that the pathway starting from a neutral Asp110 yields an activation free energy barrier of 20.34 kcal·mol-1─nearly half that of the alternative pathway that considers an ionised Asp110. The deglycosylation step of the most favorable pathway yielded a free energy barrier of 13.94 kcal·mol-1. Our simulations also support an induced-fit mechanism for the svHyal/hyaluronic acid complex, with substrate distortion (chair → boat/skew-boat) favoring a conformation that closely mimics the transition state. This distortion, along with a prealignment of Glu112, lowers the activation free energy, enhancing the susceptibility of the glycosidic bond to nucleophilic attack. The results are likely transferable to all svHyal given their high degree of interspecific similarity (>90% sequence identity). This study highlights the importance of understanding mechanistics, including detailed stereoelectronic conformations and subsite-specific interactions, for the design of novel and effective inhibitors with broad clinical and biotechnological applications.